Eton Pharmaceuticals Inc. (NASDAQ: ETON) Stock Information | RedChip

Eton Pharmaceuticals Inc. (NASDAQ: ETON) Listen to this Section


$4.03
+0.0200 ( +0.50% ) 45.6K

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Market Data


Open


$4.03

Previous close


$4.01

Volume


45.6K

Market cap


$104.12M

Day range


$3.98 - $4.23

52 week range


$3.03 - $5.81

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Feb 15, 2024
4 Insider transactions 1 Feb 15, 2024
4 Insider transactions 1 Feb 15, 2024
8-k 8K-related 16 Feb 02, 2024
10-q Quarterly Reports 60 Nov 09, 2023
8-k 8K-related 14 Nov 09, 2023
8-k 8K-related 14 Oct 04, 2023
10-q Quarterly Reports 60 Aug 10, 2023
8-k 8K-related 13 Aug 10, 2023

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.